{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:50:53Z","timestamp":1763967053351},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.clim.2009.01.007","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T09:16:27Z","timestamp":1234775787000},"page":"438-446","source":"Crossref","is-referenced-by-count":12,"title":["Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency"],"prefix":"10.1016","volume":"131","author":[{"given":"B\u00f8rre","family":"Fevang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Yndestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Brosstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Beiske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig S","family":"Fr\u00f8land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clim.2009.01.007_bib1","first-page":"1","article-title":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies","volume":"118","author":"Rosen","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","article-title":"Common variable immune deficiency and autoimmunity","volume":"5","author":"Brandt","year":"2006","journal-title":"Autoimmune Rev."},{"key":"10.1016\/j.clim.2009.01.007_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","article-title":"Common variable immunodeficiency: a review","volume":"3","author":"Di Renzo","year":"2004","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.clim.2009.01.007_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.105.591032","article-title":"Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis","volume":"114","author":"Heymans","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2009.01.007_bib6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1172\/JCI118611","article-title":"Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model","volume":"97","author":"Gyetko","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2009.01.007_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4049\/jimmunol.168.2.801","article-title":"Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection","volume":"168","author":"Gyetko","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib8","first-page":"359","article-title":"Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles","volume":"150","author":"Shapiro","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2009.01.007_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/IAI.67.2.879-884.1999","article-title":"Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice","volume":"67","author":"Beck","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2009.01.007_bib10","first-page":"2428","article-title":"Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice","volume":"56","author":"Min","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2009.01.007_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.56.9.550","article-title":"Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints","volume":"56","author":"Busso","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2009.01.007_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1440-1681.1999.03043.x","article-title":"Urokinase plasminogen activator system in humans with stable coronary artery disease","volume":"26","author":"Krasnikova","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.clim.2009.01.007_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2006-0113OC","article-title":"Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma","volume":"35","author":"Brooks","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.clim.2009.01.007_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1160\/TH04-09-0580","article-title":"Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?","volume":"93","author":"Montuori","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2009.01.007_bib15","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1093\/emboj\/16.24.7279","article-title":"A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity","volume":"16","author":"Fazioli","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2009.01.007_bib16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.165.3.1513","article-title":"Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection","volume":"165","author":"Gyetko","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib17","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.168.7.3507","article-title":"Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia","volume":"168","author":"Rijneveld","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/med.10054","article-title":"Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer","volume":"24","author":"de Bock","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.clim.2009.01.007_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.58.8.488","article-title":"Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis","volume":"58","author":"Slot","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2009.01.007_bib20","first-page":"311","article-title":"Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee","volume":"33","author":"Chu","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2009.01.007_bib21","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau","volume":"6","author":"Eugen-Olsen","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.clim.2009.01.007_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","article-title":"The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality","volume":"10","author":"Wittenhagen","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.clim.2009.01.007_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00365540310017366","article-title":"Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome","volume":"36","author":"Ostergaard","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.clim.2009.01.007_bib24","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","article-title":"Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection","volume":"96","author":"Sidenius","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.01.007_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-3083.2006.001768.x","article-title":"Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy","volume":"63","author":"Ostrowski","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.1992.tb06934.x","article-title":"Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features","volume":"89","author":"Aukrust","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2249.2005.02951.x","article-title":"Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis","volume":"142","author":"Fevang","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gde.2007.04.002","article-title":"Deconstructing common variable immunodeficiency by genetic analysis","volume":"17","author":"Schaffer","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.clim.2009.01.007_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clim.2009.01.007_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.162.2.1178","article-title":"Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency","volume":"162","author":"Aukrust","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/cyto.2000.0850","article-title":"Complex effects of interferon-alpha on the cytokine network in HIV infection\u2014possible contribution to immunosuppression","volume":"14","author":"Stylianou","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2009.01.007_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jlb.57.2.235","article-title":"Retention of phagocytic functions in cryopreserved human monocytes","volume":"57","author":"Hansen","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2009.01.007_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.01.007_bib34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/aid.2005.21.560","article-title":"Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau","volume":"21","author":"Jaffar","year":"2005","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.clim.2009.01.007_bib35","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/01.CCM.0000239120.32490.AB","article-title":"Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163","volume":"34","author":"Moller","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clim.2009.01.007_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0300-9475.2005.01547.x","article-title":"Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells","volume":"61","author":"Ostrowski","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib37","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/IAI.68.4.2156-2160.2000","article-title":"Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia","volume":"68","author":"Dekkers","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2009.01.007_bib38","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.V91.7.2305","article-title":"Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes","volume":"91","author":"Chavakis","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.01.007_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.152.2.505","article-title":"Urokinase receptor. An activation antigen in human T lymphocytes","volume":"152","author":"Nykjaer","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib40","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.2001.00719.x","article-title":"Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia","volume":"59","author":"Florquin","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2009.01.007_bib41","article-title":"The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients","author":"Pawlak","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2009.01.007_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/clin.1994.1032","article-title":"Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes","volume":"70","author":"Aukrust","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2009.01.007_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2014possible immunologic and clinical consequences","volume":"87","author":"Aukrust","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.01.007_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/S0891-5520(05)70093-3","article-title":"Pathogenesis of bacterial meningitis","volume":"13","author":"Leib","year":"1999","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.clim.2009.01.007_bib45","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.154.4.1817","article-title":"Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium","volume":"154","author":"Cao","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.01.007_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1189\/jlb.0104023","article-title":"Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro","volume":"76","author":"Gyetko","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2009.01.007_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/431600","article-title":"Urokinase-type plasminogen activator, an endogenous antibiotic","volume":"192","author":"Jin","year":"2005","journal-title":"J. Infect. Dis."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:11:05Z","timestamp":1684890665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661609000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1521661609000126"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2009.01.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}